Streetbeat News

Price Targets

POOL

Loop Capital analyst Garik Shmois maintains a Hold rating on Pool Corporation (NASDAQ:POOL) but lowers the price target from $415 to $370.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:49 pm

KALV

Needham analyst Serge Belanger reiterates a Buy rating on KalVista Pharma (NASDAQ:KALV) and maintains a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:46 pm

OVID

Citigroup analyst Yigal Nochomovitz maintains a Neutral rating on Ovid Therapeutics (NASDAQ:OVID) but lowers the price target from $3.5 to $1.2.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:44 pm

AMAT

Applied Materials shares are trading higher due to strength in chip stocks and a price target increase by Wells Fargo.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:43 pm

MIRM

Citigroup analyst David Lebowitz maintains a Buy rating on Mirum Pharmaceuticals (NASDAQ:MIRM) and raises the price target from $38 to $64.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:43 pm

SUN

Citigroup analyst Spiro Dounis has upgraded Sunoco (NYSE:SUN) from Neutral to Buy and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:39 pm

CEG

UBS analyst Ross Fowler maintains a Buy rating on Constellation Energy (NASDAQ:CEG) and raises the price target from $227 to $249.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:33 pm

TER

UBS analyst Timothy Arcuri maintains a Buy rating on Teradyne (NASDAQ:TER) and raises the price target from $130 to $170.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:31 pm

AVTE

Wells Fargo analyst Tiago Fauth has downgraded Aerovate Therapeutics (NASDAQ:AVTE) from Overweight to Equal-Weight and significantly lowered the price target from $35 to $2.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:28 pm